ATE245028T1 - Trimegestone enthaltende pharmazeutische zusammensetzungen - Google Patents

Trimegestone enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE245028T1
ATE245028T1 AT00981453T AT00981453T ATE245028T1 AT E245028 T1 ATE245028 T1 AT E245028T1 AT 00981453 T AT00981453 T AT 00981453T AT 00981453 T AT00981453 T AT 00981453T AT E245028 T1 ATE245028 T1 AT E245028T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
trimegestone
containing trimegestone
composition
Prior art date
Application number
AT00981453T
Other languages
English (en)
Inventor
Philippe Becourt
Robert Georges
Chicq Serge Segot
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE245028T1 publication Critical patent/ATE245028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00981453T 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen ATE245028T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9914714A FR2801218B1 (fr) 1999-11-23 1999-11-23 Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
PCT/FR2000/003240 WO2001037841A1 (fr) 1999-11-23 2000-11-22 Compositions pharmaceutiques comprenant de la trimegestone

Publications (1)

Publication Number Publication Date
ATE245028T1 true ATE245028T1 (de) 2003-08-15

Family

ID=9552429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00981453T ATE245028T1 (de) 1999-11-23 2000-11-22 Trimegestone enthaltende pharmazeutische zusammensetzungen

Country Status (11)

Country Link
US (1) US7732431B2 (de)
EP (1) EP1235579B1 (de)
JP (1) JP5060005B2 (de)
AT (1) ATE245028T1 (de)
AU (1) AU1869601A (de)
DE (1) DE60003943T2 (de)
DK (1) DK1235579T3 (de)
ES (1) ES2200978T3 (de)
FR (1) FR2801218B1 (de)
PT (1) PT1235579E (de)
WO (1) WO2001037841A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200306196A (en) * 2002-04-03 2003-11-16 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
CA2615427A1 (en) * 2005-07-20 2007-01-25 Oliver Gloger Oral contraception with trimegestone
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
EP2108371A1 (de) * 2008-04-08 2009-10-14 Grünenthal GmbH Estra-1,3,5(10)-trien-Derivate zur Kontrazeption
US9271991B2 (en) 2010-10-27 2016-03-01 Dignity Health Trimegestone (TMG) for treatment of preterm birth
EP3019172B1 (de) * 2013-07-11 2019-09-25 Evestra, Inc. Verbindungen zur herstellung von prodrugs
WO2018136702A1 (en) 2017-01-23 2018-07-26 Regeneron Pharmaceuticals, Inc. Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
KR20190139869A (ko) * 2017-04-11 2019-12-18 리제너론 파마슈티칼스 인코포레이티드 하이드록시스테로이드 (17-베타) 탈수소효소(hsd17b) 패밀리의 구성원의 조절인자의 활성도를 스크리닝하기 위한 검정
SG11202003254SA (en) 2017-10-11 2020-05-28 Regeneron Pharma Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m variation
BR112020007673A2 (pt) 2017-10-19 2020-10-13 Evestra, Inc. contraceptivos pró-fármaco de progestina de ação prolongada
AU2019239971A1 (en) 2018-03-21 2020-09-03 Regeneron Pharmaceuticals, Inc. 17beta-hydroxysteroid dehydrogenase type 13 (HSD17b13) iRNA compositions and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4239646A (en) * 1974-09-23 1980-12-16 Champion International Corporation Microspheric opacifying agents and method for their production
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.
FR2694007B1 (fr) * 1992-07-23 1994-09-30 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21 (S) hydroxy et des intermédiaires.
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
CZ289133B6 (cs) * 1995-06-22 2001-11-14 Akzo Nobel N. V. Výlisek, tablety nebo granule a způsob jejich výroby
FR2749012B1 (fr) * 1996-05-22 1998-08-07 Hoechst Marion Roussel Inc Nouveaux steroides 1 ou 6-hydroxyles, leur procede de preparation, leur application a titre de medicament et les compositions pharmaceutiques les renfermant
ATE249222T1 (de) * 1996-07-26 2003-09-15 Wyeth Corp Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
KR100518102B1 (ko) * 1996-07-26 2005-10-04 와이어쓰 프로게스틴과 에스트로겐의 혼합물을 포함하는 단일상 피임약 키트
EP0917466B1 (de) * 1996-07-26 2004-10-06 Wyeth Orales contrazeptivum
SG125044A1 (en) * 1996-10-14 2006-09-29 Mitsubishi Gas Chemical Co Oxygen absorption composition
US6329416B1 (en) * 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives

Also Published As

Publication number Publication date
US20070219169A1 (en) 2007-09-20
EP1235579B1 (de) 2003-07-16
AU1869601A (en) 2001-06-04
FR2801218B1 (fr) 2001-12-28
FR2801218A1 (fr) 2001-05-25
JP5060005B2 (ja) 2012-10-31
DE60003943T2 (de) 2004-05-27
DE60003943D1 (de) 2003-08-21
ES2200978T3 (es) 2004-03-16
US7732431B2 (en) 2010-06-08
EP1235579A1 (de) 2002-09-04
JP2003514861A (ja) 2003-04-22
PT1235579E (pt) 2003-12-31
WO2001037841A1 (fr) 2001-05-31
DK1235579T3 (da) 2003-10-20

Similar Documents

Publication Publication Date Title
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
MY126897A (en) Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
AP9901534A0 (en) Pharmaceutical formulations.
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
YU15299A (sh) Farmaceutski sastavi
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
MY124487A (en) Dolastatin derivatives, their preparation and use
GB2364641A (en) Stabilized oral pharmaceutical composition containing iodide and iodate and method
HK1029060A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
YU13301A (sh) Muskarinski agonisti i antagonisti
AU9534398A (en) Novel pharmaceutical composition
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
PH30665A (en) Aminosulfonyl urea acat inhibitors
BG105539A (en) Eletriptan hydrobromide monohydrate
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
ES2191625T3 (es) Composicion oral que contiene perlita.
IL128500A (en) SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES2179375T3 (es) Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion.
MXPA01011296A (es) Composiciones contraceptivas que contienen derivados de indolina y agentes progestacionales.
DE69900466D1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1235579

Country of ref document: EP